Agence France-Presse

Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical trial of ME3241 ...
科学技術振興機構

Strategic International Collaborative Research Program (SICORP) Information on Japan (JST ...

The Japan Science and Technology Agency (JST) and the National Research Foundation of Korea (NRF), in order to promote international research interaction and exchange among researchers in Japan and ...
科学技術振興機構

AJ-CORE (Africa-Japan Collaborative Research) 第4回公募のお知らせ

「公募説明会」を追記致しました。 （令和6年6月） 国立研究開発法人科学技術振興機構（JST）では、日本-南アフリカを核とする3ヶ国以上の日・アフリカ多国間共同研究プログラムであるAJ-CORE (Africa-Japan Collaborative Research) において、「地球環境科学 ...
USA Today

MoltCure Launches First Multi-Agent AI Platform for Collaborative Biomedical Research

PALATINE, IL / ACCESS Newswire / February 3, 2026 / MoltCure, a groundbreaking collaborative AI research platform, today announced its public launch following successful beta testing with over 2,800 ...